Consensus report from the 6th International forum for liver MRI using gadoxetic acid

Claude B. Sirlin, Hero K. Hussain, Eduard Jonas, Masayuki Kanematsu, Jeong Min Lee, Elmar M. Merkle, Markus Peck-Radosavljevic, Scott B. Reeder, Jens Ricke, Michiie Sakamoto

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

As the utility of liver-specific magnetic resonance imaging (MRI) increases, it is pertinent to optimize and expand protocols to improve accuracy and foster evolution of techniques; in turn, positive impacts should be seen in patient management. This article reports on the latest expert thinking and current evidence in the field of liver-specific MRI, as discussed at the 6 th International Forum for Liver MRI, which was held in Vancouver, Canada in September 2012. Topics discussed at this forum described the use of gadoxetic acid-enhanced MRI for the assessment of liver function at the segmental level; to increase accuracy in the diagnosis of liver metastases; to overcome current challenges in patients with cirrhosis, including management of arterial hypo-/isovascular, hepatobiliary phase hypointense nodules; and the data which would be required in order to recommend the use of this modality in hepatocellular carcinoma management guidelines. Growing evidence suggests that gadoxetic acid-enhanced MRI can help to improve the management of patients with a number of different liver disorders; however, more data are needed in some areas, and there may be a case for developing an interpretation guideline for gadoxetic acid-enhanced MRI findings to aid standardization.

Original languageEnglish
Pages (from-to)516-529
Number of pages14
JournalJournal of Magnetic Resonance Imaging
Volume40
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Magnetic Resonance Imaging
Liver
Guidelines
Canada
gadolinium ethoxybenzyl DTPA
Hepatocellular Carcinoma
Fibrosis
Neoplasm Metastasis

Keywords

  • cirrhosis
  • consensus report
  • gadoxetic acid
  • gadoxetic disodium
  • hepatocellular carcinoma management guidelines
  • International forum for liver MRI
  • liver function
  • liver metastases

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Consensus report from the 6th International forum for liver MRI using gadoxetic acid. / Sirlin, Claude B.; Hussain, Hero K.; Jonas, Eduard; Kanematsu, Masayuki; Min Lee, Jeong; Merkle, Elmar M.; Peck-Radosavljevic, Markus; Reeder, Scott B.; Ricke, Jens; Sakamoto, Michiie.

In: Journal of Magnetic Resonance Imaging, Vol. 40, No. 3, 2014, p. 516-529.

Research output: Contribution to journalArticle

Sirlin, CB, Hussain, HK, Jonas, E, Kanematsu, M, Min Lee, J, Merkle, EM, Peck-Radosavljevic, M, Reeder, SB, Ricke, J & Sakamoto, M 2014, 'Consensus report from the 6th International forum for liver MRI using gadoxetic acid', Journal of Magnetic Resonance Imaging, vol. 40, no. 3, pp. 516-529. https://doi.org/10.1002/jmri.24419
Sirlin, Claude B. ; Hussain, Hero K. ; Jonas, Eduard ; Kanematsu, Masayuki ; Min Lee, Jeong ; Merkle, Elmar M. ; Peck-Radosavljevic, Markus ; Reeder, Scott B. ; Ricke, Jens ; Sakamoto, Michiie. / Consensus report from the 6th International forum for liver MRI using gadoxetic acid. In: Journal of Magnetic Resonance Imaging. 2014 ; Vol. 40, No. 3. pp. 516-529.
@article{9bb3917f7b9e41929b4b1f364f91be15,
title = "Consensus report from the 6th International forum for liver MRI using gadoxetic acid",
abstract = "As the utility of liver-specific magnetic resonance imaging (MRI) increases, it is pertinent to optimize and expand protocols to improve accuracy and foster evolution of techniques; in turn, positive impacts should be seen in patient management. This article reports on the latest expert thinking and current evidence in the field of liver-specific MRI, as discussed at the 6 th International Forum for Liver MRI, which was held in Vancouver, Canada in September 2012. Topics discussed at this forum described the use of gadoxetic acid-enhanced MRI for the assessment of liver function at the segmental level; to increase accuracy in the diagnosis of liver metastases; to overcome current challenges in patients with cirrhosis, including management of arterial hypo-/isovascular, hepatobiliary phase hypointense nodules; and the data which would be required in order to recommend the use of this modality in hepatocellular carcinoma management guidelines. Growing evidence suggests that gadoxetic acid-enhanced MRI can help to improve the management of patients with a number of different liver disorders; however, more data are needed in some areas, and there may be a case for developing an interpretation guideline for gadoxetic acid-enhanced MRI findings to aid standardization.",
keywords = "cirrhosis, consensus report, gadoxetic acid, gadoxetic disodium, hepatocellular carcinoma management guidelines, International forum for liver MRI, liver function, liver metastases",
author = "Sirlin, {Claude B.} and Hussain, {Hero K.} and Eduard Jonas and Masayuki Kanematsu and {Min Lee}, Jeong and Merkle, {Elmar M.} and Markus Peck-Radosavljevic and Reeder, {Scott B.} and Jens Ricke and Michiie Sakamoto",
year = "2014",
doi = "10.1002/jmri.24419",
language = "English",
volume = "40",
pages = "516--529",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Consensus report from the 6th International forum for liver MRI using gadoxetic acid

AU - Sirlin, Claude B.

AU - Hussain, Hero K.

AU - Jonas, Eduard

AU - Kanematsu, Masayuki

AU - Min Lee, Jeong

AU - Merkle, Elmar M.

AU - Peck-Radosavljevic, Markus

AU - Reeder, Scott B.

AU - Ricke, Jens

AU - Sakamoto, Michiie

PY - 2014

Y1 - 2014

N2 - As the utility of liver-specific magnetic resonance imaging (MRI) increases, it is pertinent to optimize and expand protocols to improve accuracy and foster evolution of techniques; in turn, positive impacts should be seen in patient management. This article reports on the latest expert thinking and current evidence in the field of liver-specific MRI, as discussed at the 6 th International Forum for Liver MRI, which was held in Vancouver, Canada in September 2012. Topics discussed at this forum described the use of gadoxetic acid-enhanced MRI for the assessment of liver function at the segmental level; to increase accuracy in the diagnosis of liver metastases; to overcome current challenges in patients with cirrhosis, including management of arterial hypo-/isovascular, hepatobiliary phase hypointense nodules; and the data which would be required in order to recommend the use of this modality in hepatocellular carcinoma management guidelines. Growing evidence suggests that gadoxetic acid-enhanced MRI can help to improve the management of patients with a number of different liver disorders; however, more data are needed in some areas, and there may be a case for developing an interpretation guideline for gadoxetic acid-enhanced MRI findings to aid standardization.

AB - As the utility of liver-specific magnetic resonance imaging (MRI) increases, it is pertinent to optimize and expand protocols to improve accuracy and foster evolution of techniques; in turn, positive impacts should be seen in patient management. This article reports on the latest expert thinking and current evidence in the field of liver-specific MRI, as discussed at the 6 th International Forum for Liver MRI, which was held in Vancouver, Canada in September 2012. Topics discussed at this forum described the use of gadoxetic acid-enhanced MRI for the assessment of liver function at the segmental level; to increase accuracy in the diagnosis of liver metastases; to overcome current challenges in patients with cirrhosis, including management of arterial hypo-/isovascular, hepatobiliary phase hypointense nodules; and the data which would be required in order to recommend the use of this modality in hepatocellular carcinoma management guidelines. Growing evidence suggests that gadoxetic acid-enhanced MRI can help to improve the management of patients with a number of different liver disorders; however, more data are needed in some areas, and there may be a case for developing an interpretation guideline for gadoxetic acid-enhanced MRI findings to aid standardization.

KW - cirrhosis

KW - consensus report

KW - gadoxetic acid

KW - gadoxetic disodium

KW - hepatocellular carcinoma management guidelines

KW - International forum for liver MRI

KW - liver function

KW - liver metastases

UR - http://www.scopus.com/inward/record.url?scp=84906087256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906087256&partnerID=8YFLogxK

U2 - 10.1002/jmri.24419

DO - 10.1002/jmri.24419

M3 - Article

C2 - 24923695

AN - SCOPUS:84906087256

VL - 40

SP - 516

EP - 529

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 3

ER -